Dare Bioscience, Inc (DARE) Stock Price

1.98 ▼ -0.09 (-4.35%)
Open: 2.07 Vol: 27.24K Day's range: 1.98 - 2.07 Jan 09, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DARE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.98▲ 1.98▲ 1.98▲ 1.99▼ 2.13▼
MA10 1.98▲ 1.98▲ 1.98▲ 2.00▼ 1.96▲
MA20 1.97▲ 1.97▲ 1.96▲ 2.12▼ 2.03▼
MA50 1.95▲ 1.97▲ 2.02▲ 1.94▲ 2.48▼
MA100 2.00▲ 2.05▼ 2.14▼ 2.02▼ 3.30▼
MA200 2.07▼ 2.11▼ 1.97▲ 2.38▼ 7.09▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.005▲ 0.007▲ 0.013▲ -0.020▼ 0.043▲
RSI 60.604▲ 59.165▲ 56.698▲ 47.862▼ 45.272▼
STOCH 36.111     36.111     67.424     30.897     50.861    
WILL %R 0.000▲ 0.000▲ 0.000▲ -80.645▼ -60.215    
CCI 173.994▲ 176.549▲ 148.831▲ -33.465     -9.806    
Latest Filters Detected On DARE
RSI $DARE RSI(14) Crossed Below 50 Set Alert
MA $DARE Price Crossed Below MA(26) Set Alert
MA $DARE Price Crossed Below MA(13) Set Alert
CDL $DARE Marubozu Candlestick Pattern Detected Set Alert
Dare Bioscience, Inc News
DARE to PLAY™ Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States ...
Wednesday, December 10, 2025 05:00 AM
Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non-hormonal topical cream shown in clinical studies to increase genital ...
Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
Monday, December 01, 2025 05:00 AM
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science ...
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
Monday, November 24, 2025 05:00 AM
Grant funding will support continued progress on a preclinical research program to identify and develop a non-hormonal intravaginal contraceptive innovation aimed at addressing unmet global needs SAN ...
DARE historical stock data
date open high low close volume
09/01/26 2.07 2.07 1.98 1.98 27,243
08/01/26 1.97 2.07 1.97 2.07 125,198
07/01/26 1.97 2.01 1.89 1.97 95,837
06/01/26 1.96 2.02 1.96 1.96 48,005
05/01/26 1.98 2.031 1.95 1.99 44,649
02/01/26 1.93 2.0792 1.90 1.95 73,721
31/12/25 1.96 1.9802 1.90 1.93 156,816
30/12/25 2.00 2.039 1.949 1.96 158,280
29/12/25 2.13 2.14 1.98 2.00 251,321
26/12/25 2.19 2.19 2.09 2.15 90,676
Quote Details
52wk Low:1.61
52wk High:9.19
Vol:27.24K
Avg Vol(3m):2.9M
1Y Chng:-39.45%
1M Chng:+9.39%
Add to Watch List
More Information
Index US Composite
Market Cap. 27.90M